Treatment of Active Corticosteroid-Resistant Graves’ Orbitopathy

2014193 citationsJournal Article

Authors

J.V. Pérez-Moreiras · Centro Oftalmológico Moreiras

Alejandro Álvarez-López · Centro Oftalmológico Moreiras

Estanislao Cardiel Gómez · Hospital Royo Villanova

Abstract

This study suggests that intravenous Tocilizumab may be effective on reducing activity in patients with thyroid eye disease refractory to intravenous steroids.

Topics & Keywords

Ophthalmology and Eye Disorders Glaucoma and retinal disorders Cerebral Venous Sinus Thrombosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Ophthalmic Plastic and Reconstructive Surgery

Volume 30, Issue 2, pp. 162-167

DOI: 10.1097/iop.0000000000000037

Field-Weighted Citation Impact: 8.46